Abstract

Constructs derived from mammalian cells are emerging as a new generation of nano-scale platforms for clinical imaging applications. Herein, we report successful engineering of hybrid nano-structures composed of erythrocyte-derived membranes doped with FDA-approved near infrared (NIR) chromophore, indocyanine green (ICG), and surface-functionalized with antibodies to achieve molecular targeting. We demonstrate that these constructs can be used for targeted imaging of cancer cells in vitro. These erythrocyte-derived optical nano-probes may provide a potential platform for clinical translation, and enable molecular imaging of cancer biomarkers.

© 2016 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging

Jun Qian, Xin Li, Ming Wei, Xiangwei Gao, Zhengping Xu, and Sailing He
Opt. Express 16(24) 19568-19578 (2008)

In vivo Photoacoustic Molecular Imaging with Simultaneous Multiple Selective Targeting Using Antibody-Conjugated Gold Nanorods

Pai-Chi Li, Churng-Ren Chris Wang, Dar-Bin Shieh, Chen-Wei Wei, Chao-Kang Liao, Carolina Poe, Suwen Jhan, Ann-Ann Ding, and Ya-Na Wu
Opt. Express 16(23) 18605-18615 (2008)

Gold nanoshell bioconjugates for molecular imaging in living cells

Christopher Loo, Leon Hirsch, Min-Ho Lee, Emmanuel Chang, Jennifer West, Naomi Halas, and Rebekah Drezek
Opt. Lett. 30(9) 1012-1014 (2005)

References

  • View by:
  • |
  • |
  • |

  1. J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Curr. Opin. Chem. Biol. 7(5), 626–634 (2003).
    [Crossref] [PubMed]
  2. W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
    [Crossref]
  3. S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
    [Crossref] [PubMed]
  4. L. A. Yannuzzi, “Indocyanine Green Angiography: A Perspective On Use In The Clinical Setting,” Am. J. Ophthalmol. 151(5), 745–751 (2011).
    [Crossref] [PubMed]
  5. C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
    [Crossref] [PubMed]
  6. E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
    [Crossref] [PubMed]
  7. L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
    [Crossref] [PubMed]
  8. J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
    [Crossref] [PubMed]
  9. S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
    [Crossref] [PubMed]
  10. H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
    [Crossref] [PubMed]
  11. K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
    [Crossref] [PubMed]
  12. J. C. Kraft and R. J. Ho, “Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo,” Biochemistry 53(8), 1275–1283 (2014).
    [Crossref] [PubMed]
  13. T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
    [Crossref] [PubMed]
  14. L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
    [Crossref] [PubMed]
  15. M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
    [Crossref] [PubMed]
  16. M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
    [Crossref] [PubMed]
  17. P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
    [Crossref] [PubMed]
  18. G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
    [Crossref] [PubMed]
  19. B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
    [PubMed]
  20. C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
    [Crossref] [PubMed]
  21. A. Antonelli and M. Magnani, “Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications,” J. Biomed. Nanotechnol. 10(9), 1732–1750 (2014).
    [Crossref] [PubMed]
  22. V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
    [PubMed]
  23. C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
    [Crossref] [PubMed]
  24. V. R. Muzykantov, “Drug delivery by red blood cells: vascular carriers designed by mother nature,” Expert Opin. Drug Deliv. 7(4), 403–427 (2010).
    [Crossref] [PubMed]
  25. J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
    [Crossref] [PubMed]
  26. A. A. Bentley and J. C. Adams, “The Evolution Of Thrombospondins And Their Ligand-Binding Activities,” Mol. Biol. Evol. 27(9), 2187–2197 (2010).
    [Crossref] [PubMed]
  27. P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
    [Crossref] [PubMed]
  28. P. A. Oldenborg, “CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease,” ISRN Hematol. 2013, 614619 (2013).
    [Crossref] [PubMed]
  29. P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
    [Crossref] [PubMed]
  30. B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
    [Crossref] [PubMed]
  31. M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
    [Crossref] [PubMed]
  32. D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
    [Crossref] [PubMed]
  33. R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
    [Crossref] [PubMed]
  34. J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
    [Crossref] [PubMed]
  35. V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
    [Crossref] [PubMed]
  36. B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).
  37. D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
    [Crossref]
  38. Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
    [Crossref] [PubMed]
  39. T. Tadros, “Steric Stabilization,” in Encyclopedia of Colloid and Interface Science, T. Tadros, ed. (Springer Berlin Heidelberg, Berlin, Heidelberg, 2013), pp. 1048–1049.
  40. S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
    [Crossref]
  41. R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
    [Crossref] [PubMed]
  42. C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
    [Crossref] [PubMed]
  43. J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
    [Crossref] [PubMed]
  44. B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
    [Crossref] [PubMed]
  45. F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
    [Crossref] [PubMed]
  46. L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
    [Crossref] [PubMed]
  47. J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
    [Crossref] [PubMed]
  48. N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
    [Crossref] [PubMed]
  49. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
    [Crossref] [PubMed]

2015 (1)

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

2014 (7)

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

J. C. Kraft and R. J. Ho, “Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo,” Biochemistry 53(8), 1275–1283 (2014).
[Crossref] [PubMed]

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

A. Antonelli and M. Magnani, “Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications,” J. Biomed. Nanotechnol. 10(9), 1732–1750 (2014).
[Crossref] [PubMed]

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).

2013 (10)

D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
[Crossref] [PubMed]

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

P. A. Oldenborg, “CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease,” ISRN Hematol. 2013, 614619 (2013).
[Crossref] [PubMed]

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
[Crossref] [PubMed]

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

2012 (5)

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
[Crossref] [PubMed]

2011 (6)

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

L. A. Yannuzzi, “Indocyanine Green Angiography: A Perspective On Use In The Clinical Setting,” Am. J. Ophthalmol. 151(5), 745–751 (2011).
[Crossref] [PubMed]

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

2010 (5)

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

A. A. Bentley and J. C. Adams, “The Evolution Of Thrombospondins And Their Ligand-Binding Activities,” Mol. Biol. Evol. 27(9), 2187–2197 (2010).
[Crossref] [PubMed]

V. R. Muzykantov, “Drug delivery by red blood cells: vascular carriers designed by mother nature,” Expert Opin. Drug Deliv. 7(4), 403–427 (2010).
[Crossref] [PubMed]

2009 (1)

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

2008 (5)

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

2007 (3)

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

2005 (1)

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

2003 (1)

J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Curr. Opin. Chem. Biol. 7(5), 626–634 (2003).
[Crossref] [PubMed]

2000 (1)

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

1999 (1)

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

1990 (1)

W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
[Crossref]

Abla, A. A.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Adair, J. H.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Adams, J. C.

A. A. Bentley and J. C. Adams, “The Evolution Of Thrombospondins And Their Ligand-Binding Activities,” Mol. Biol. Evol. 27(9), 2187–2197 (2010).
[Crossref] [PubMed]

Adams, K. E.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Agayan, R. R.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Agrawal, V.

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Albuquerque, F. C.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Allal, C.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Allouni, Z. E.

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Altinoglu, E. I.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Andriulli, A.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Annese, V.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Antonelli, A.

A. Antonelli and M. Magnani, “Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications,” J. Biomed. Nanotechnol. 10(9), 1732–1750 (2014).
[Crossref] [PubMed]

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Anvari, B.

B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
[Crossref] [PubMed]

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

Aoki, A.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Arts, H. J.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Aryal, S.

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Ashkenazi, S.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Bacon, D.

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
[Crossref] [PubMed]

Bahmani, B.

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
[Crossref] [PubMed]

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Bain, M. D.

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Bax, B. E.

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Bengtsson, N. E.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Bentley, A. A.

A. A. Bentley and J. C. Adams, “The Evolution Of Thrombospondins And Their Ligand-Binding Activities,” Mol. Biol. Evol. 27(9), 2187–2197 (2010).
[Crossref] [PubMed]

Blanchard, D. K.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Bonefas, E.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Borgert, J.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Borthakur, G.

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Bossa, F.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Brouwers, A. H.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Bu, L. L.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Buchfelder, M.

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Buddingh, K. T.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Bugat, R.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Cai, B.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Cai, L.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Canal, M.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Canal, P.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Carpenter, C. W.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Chalmers, R. A.

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Chatelut, E.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Chen, K. N.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Cheong, W. F.

W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
[Crossref]

Cheung, C.

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Chiang, S. B.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Chowdhry, S. A.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Christian, D. A.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

Cimpan, M. R.

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Colino Gandarillas, C. I.

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

Crane, L. M.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Dallapiccola, B.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Damonte, G.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Day, K. C.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Day, M. A.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

De Santo, E.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Delord, J. P.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Deng, J.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Diendorf, J.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Discher, D. E.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

Dörfler, A.

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Elledge, R.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

English, D. P.

D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
[Crossref] [PubMed]

Epple, M.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

Fang, R. H.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
[Crossref] [PubMed]

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Fang, S.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Fang, Y. F.

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Farokhzad, O. C.

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Fisher, R. E.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Flower, R.

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Fox, T.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Frangioni, J. V.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Curr. Opin. Chem. Biol. 7(5), 626–634 (2003).
[Crossref] [PubMed]

Frankel, A. E.

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Fujinami, M.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Fujito, H.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Ganslandt, O.

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Gao, W.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Gebauer, J. S.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Gjerdet, N. R.

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Gleich, B.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Gonzalez-Calbet, J. M.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Gresham, H. D.

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Greulich, C.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

Grobmyer, S. R.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Gryczynski, I.

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Gryczynski, Z.

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Guichard, S.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Guo, S. S.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Gupta, S.

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Gutiérrez Millán, C.

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

Hansson, M.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Harada, T.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

Hayashi, H.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

He, Z.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Heakal, Y.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Hennebelle, I.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Hilderbrand, S. A.

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

Hirche, C.

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Ho, R. J.

J. C. Kraft and R. J. Ho, “Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo,” Biochemistry 53(8), 1275–1283 (2014).
[Crossref] [PubMed]

Høl, P. J.

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Hong, S.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Houston, J. P.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Hruby, S.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Hu, C. M.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
[Crossref] [PubMed]

Hu, C. M. J.

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Huang, Q.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Huang, S. W.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Hünerbein, M.

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Hutteman, M.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Irvine, D. J.

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

Iwakuma, N.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Janetschek, G.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Jeschke, S.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Jung, B. S.

B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).

Kamaly, N.

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

Kantarjian, H.

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Karp, J. M.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Kelly, K. A.

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

Kester, M.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Kim, G.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Kittler, S.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Kneif, S.

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Koller, M.

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Kopelman, R.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Kraft, J. C.

J. C. Kraft and R. J. Ho, “Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo,” Biochemistry 53(8), 1275–1283 (2014).
[Crossref] [PubMed]

Krawagna, M.

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Kurzrock, R.

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

Lagenaur, C. F.

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Lanao, J. M.

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

Langer, R.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Latiano, A.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Li, A.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Li, S.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Liefers, G. J.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Lindberg, F. P.

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Liu, B.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Liu, W.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Lu, W.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Luk, B. T.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Lusuardi, L.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Lytle, C. Y.

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Madono, T.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Magnani, M.

A. Antonelli and M. Magnani, “Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications,” J. Biomed. Nanotechnol. 10(9), 1732–1750 (2014).
[Crossref] [PubMed]

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Mahl, D.

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

Margalit, R.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Marshall, M. V.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Mawad, M. E.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Mery, E.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Meyer-Zaika, W.

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

Mitragotri, S.

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

Mohr, Z.

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Morgan, T. T.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Moudgil, B. M.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Muraki, Y.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Murawa, D.

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Muzykantov, V. R.

V. R. Muzykantov, “Drug delivery by red blood cells: vascular carriers designed by mother nature,” Expert Opin. Drug Deliv. 7(4), 403–427 (2010).
[Crossref] [PubMed]

Myatt, A.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Nakaji, P.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Niedre, M.

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

Ntziachristos, V.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

O’Donnell, M.

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

Oldenborg, P. A.

P. A. Oldenborg, “CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease,” ISRN Hematol. 2013, 614619 (2013).
[Crossref] [PubMed]

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Onoue, K.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Ooishi, A.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Orlova, A.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Ouchi, T.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Palmieri, O.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Pantano, D. A.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

Parette, M. R.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Parker, B. A.

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

Parker-Williams, E. J.

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Peer, D.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Peiretti, E.

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Pham, H. Q.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Pirich, C.

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Pradines, A.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Prahl, S. A.

W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
[Crossref]

Radovic-Moreno, A. F.

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

Rahmer, J.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Rao, L.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Rasmussen, J. C.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Robertson, G. P.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Rochaix, P.

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Rodriguez, P. L.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

Roessler, K.

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Roque, D. M.

D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
[Crossref] [PubMed]

Rossi, L.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Rouse, S. M.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Ruiz, L.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Ruiz-Velasco, V.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Sampath, L.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Sandström, M.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Santin, A. D.

D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
[Crossref] [PubMed]

Sayalero Marinero, M. L.

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

Schaafsma, B. E.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Schwab, R.

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

Scott, E. W.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Serafini, S.

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

Sevick-Muraca, E. M.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Sfara, C.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Sharma, A.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Sharma, P.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Sharma, R.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Shi, J.

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

Shi, S.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Skodvin, T.

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Sohn, H. B.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Spetzler, R. F.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Suganami, A.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Sun, Z. J.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Swijnenburg, R. J.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Tabakovic, A.

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Talbot, P. J.

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Tamura, Y.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Themelis, G.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Tiemann, B.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Tolmachev, V.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Toyota, T.

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Treuel, L.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Tsai, R. K.

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

Vahrmeijer, A. L.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Valencia, P. M.

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

Vallet-Regi, M.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

van Dam, G. M.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

van de Velde, C. J.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

van der Vorst, J. R.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

van der Zee, A. G.

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

Verbeek, F. P.

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Vullev, V. I.

B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Walker, A. M.

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Wallberg, H.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Walter, G. A.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Wang, H.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Wang, T. H.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Weissleder, R.

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

Weizenecker, J.

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Welch, A. J.

W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
[Crossref]

Wendt, J. A.

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Wennborg, A.

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Wong, M. S.

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

Woo, J. H.

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Wu, L.

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Xiao, Z.

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

Xu, J. H.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Yan, M.

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

Yannuzzi, L. A.

L. A. Yannuzzi, “Indocyanine Green Angiography: A Perspective On Use In The Clinical Setting,” Am. J. Ophthalmol. 151(5), 745–751 (2011).
[Crossref] [PubMed]

Yaseen, M. A.

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

Yoo, J. W.

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

Yu, G. T.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Yu, J.

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

Yu, X.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Zaidi, H. A.

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Zellner, R.

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Zeng, H.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Zhang, D. E.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Zhang, L.

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
[Crossref] [PubMed]

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Zhang, W. F.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Zhao, X. Z.

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Zheleznyak, A.

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Zhou, G.

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

Acc. Chem. Res. (1)

J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation,” Acc. Chem. Res. 44(10), 1123–1134 (2011).
[Crossref] [PubMed]

Adv. Healthc. Mater. (1)

C. M. Hu, R. H. Fang, and L. Zhang, “Erythrocyte-inspired delivery systems,” Adv. Healthc. Mater. 1(5), 537–547 (2012).
[Crossref] [PubMed]

Am. J. Gastroenterol. (1)

F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, “Erythrocyte-Mediated Delivery Of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study,” Am. J. Gastroenterol. 103(10), 2509–2516 (2008).
[Crossref] [PubMed]

Am. J. Ophthalmol. (1)

L. A. Yannuzzi, “Indocyanine Green Angiography: A Perspective On Use In The Clinical Setting,” Am. J. Ophthalmol. 151(5), 745–751 (2011).
[Crossref] [PubMed]

Ann. Oncol. (1)

J. P. Delord, C. Allal, M. Canal, E. Mery, P. Rochaix, I. Hennebelle, A. Pradines, E. Chatelut, R. Bugat, S. Guichard, and P. Canal, “Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma,” Ann. Oncol. 16(12), 1889–1897 (2005).
[Crossref] [PubMed]

Biochemistry (1)

J. C. Kraft and R. J. Ho, “Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo,” Biochemistry 53(8), 1275–1283 (2014).
[Crossref] [PubMed]

Bioconjug. Chem. (1)

S. A. Hilderbrand, K. A. Kelly, M. Niedre, and R. Weissleder, “Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging,” Bioconjug. Chem. 19(8), 1635–1639 (2008).
[Crossref] [PubMed]

Biomacromolecules (1)

L. Wu, S. Fang, S. Shi, J. Deng, B. Liu, and L. Cai, “Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study,” Biomacromolecules 14(9), 3027–3033 (2013).
[Crossref] [PubMed]

Bioorg. Med. Chem. (1)

T. Toyota, H. Fujito, A. Suganami, T. Ouchi, A. Ooishi, A. Aoki, K. Onoue, Y. Muraki, T. Madono, M. Fujinami, Y. Tamura, and H. Hayashi, “Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives,” Bioorg. Med. Chem. 22(2), 721–727 (2014).
[Crossref] [PubMed]

Br. J. Dermatol. (1)

J. R. van der Vorst, B. E. Schaafsma, F. P. Verbeek, R. J. Swijnenburg, M. Hutteman, G. J. Liefers, C. J. van de Velde, J. V. Frangioni, and A. L. Vahrmeijer, “Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma,” Br. J. Dermatol. 168(1), 93–98 (2013).
[Crossref] [PubMed]

Breast Cancer Res. Treat. (1)

C. Hirche, D. Murawa, Z. Mohr, S. Kneif, and M. Hünerbein, “ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer,” Breast Cancer Res. Treat. 121(2), 373–378 (2010).
[Crossref] [PubMed]

Cancer Treat. Rev. (1)

M. Yan, B. A. Parker, R. Schwab, and R. Kurzrock, “HER2 aberrations in cancer: implications for therapy,” Cancer Treat. Rev. 40(6), 770–780 (2014).
[Crossref] [PubMed]

Chem. Soc. Rev. (1)

N. Kamaly, Z. Xiao, P. M. Valencia, A. F. Radovic-Moreno, and O. C. Farokhzad, “Targeted polymeric therapeutic nanoparticles: design, development and clinical translation,” Chem. Soc. Rev. 41(7), 2971–3010 (2012).
[Crossref] [PubMed]

Clin. Sci. (1)

B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, “Survival of human carrier erythrocytes in vivo,” Clin. Sci. 96(2), 171–178 (1999).
[Crossref] [PubMed]

Colloids Surf. B Biointerfaces (1)

Z. E. Allouni, M. R. Cimpan, P. J. Høl, T. Skodvin, and N. R. Gjerdet, “Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium,” Colloids Surf. B Biointerfaces 68(1), 83–87 (2009).
[Crossref] [PubMed]

Curr. Opin. Chem. Biol. (1)

J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Curr. Opin. Chem. Biol. 7(5), 626–634 (2003).
[Crossref] [PubMed]

Eur. J. Nucl. Med. Mol. Imaging (1)

V. Tolmachev, H. Wallberg, M. Sandström, M. Hansson, A. Wennborg, and A. Orlova, “Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 531–539 (2011).
[Crossref] [PubMed]

Expert Opin. Drug Deliv. (1)

V. R. Muzykantov, “Drug delivery by red blood cells: vascular carriers designed by mother nature,” Expert Opin. Drug Deliv. 7(4), 403–427 (2010).
[Crossref] [PubMed]

Gynecol. Oncol. (1)

L. M. Crane, G. Themelis, H. J. Arts, K. T. Buddingh, A. H. Brouwers, V. Ntziachristos, G. M. van Dam, and A. G. van der Zee, “Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results,” Gynecol. Oncol. 120(2), 291–295 (2011).
[Crossref] [PubMed]

IEEE J. Quantum Electron. (1)

W. F. Cheong, S. A. Prahl, and A. J. Welch, “A Review of the Optical-Properties of Biological Tissues,” IEEE J. Quantum Electron. 26(12), 2166–2185 (1990).
[Crossref]

IEEE J. Sel. Top. Quantum Electron. (1)

B. S. Jung, V. I. Vullev, and B. Anvari, “Revisiting Indocyanine Green: Effects of serum and physiological temperature on absorption and fluorescence characteristics,” IEEE J. Sel. Top. Quantum Electron. 20, 700409 (2014).

Int. J. Nanomedicine (1)

B. Bahmani, C. Y. Lytle, A. M. Walker, S. Gupta, V. I. Vullev, and B. Anvari, “Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs,” Int. J. Nanomedicine 8, 1609–1620 (2013).
[PubMed]

Invest. Ophthalmol. Vis. Sci. (1)

R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, “Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells,” Invest. Ophthalmol. Vis. Sci. 49(12), 5510–5516 (2008).
[Crossref] [PubMed]

ISRN Hematol. (1)

P. A. Oldenborg, “CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease,” ISRN Hematol. 2013, 614619 (2013).
[Crossref] [PubMed]

J. Biomed. Nanotechnol. (1)

A. Antonelli and M. Magnani, “Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications,” J. Biomed. Nanotechnol. 10(9), 1732–1750 (2014).
[Crossref] [PubMed]

J. Biomed. Opt. (2)

G. Kim, S. W. Huang, K. C. Day, M. O’Donnell, R. R. Agayan, M. A. Day, R. Kopelman, and S. Ashkenazi, “Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging,” J. Biomed. Opt. 12(4), 044020 (2007).
[Crossref] [PubMed]

M. A. Yaseen, J. Yu, M. S. Wong, and B. Anvari, “Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy,” J. Biomed. Opt. 12(6), 064031 (2007).
[Crossref] [PubMed]

J. Mater. Chem. (2)

D. Mahl, C. Greulich, W. Meyer-Zaika, M. Koller, and M. Epple, “Gold nanoparticles: dispersibility in biological media and cell-biological effect,” J. Mater. Chem. 20(29), 6176–6181 (2010).
[Crossref]

S. Kittler, C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, M. Vallet-Regi, R. Zellner, M. Koller, and M. Epple, “The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,” J. Mater. Chem. 20(3), 512–518 (2010).
[Crossref]

Mol. Biol. Evol. (1)

A. A. Bentley and J. C. Adams, “The Evolution Of Thrombospondins And Their Ligand-Binding Activities,” Mol. Biol. Evol. 27(9), 2187–2197 (2010).
[Crossref] [PubMed]

Mol. Diagn. Ther. (1)

D. P. English, D. M. Roque, and A. D. Santin, “HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies,” Mol. Diagn. Ther. 17(2), 85–99 (2013).
[Crossref] [PubMed]

Nano Lett. (1)

M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoğlu, A. Tabaković, M. R. Parette, S. M. Rouse, V. Ruiz-Velasco, and J. H. Adair, “Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells,” Nano Lett. 8(12), 4116–4121 (2008).
[Crossref] [PubMed]

Nanoscale (1)

R. H. Fang, C. M. Hu, K. N. Chen, B. T. Luk, C. W. Carpenter, W. Gao, S. Li, D. E. Zhang, W. Lu, and L. Zhang, “Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles,” Nanoscale 5(19), 8884–8888 (2013).
[Crossref] [PubMed]

Nat. Nanotechnol. (1)

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
[Crossref] [PubMed]

Nat. Rev. Drug Discov. (1)

J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengineered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov. 10(7), 521–535 (2011).
[Crossref] [PubMed]

Neurosurg. Focus (1)

K. Roessler, M. Krawagna, A. Dörfler, M. Buchfelder, and O. Ganslandt, “Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature,” Neurosurg. Focus 36(2), E7 (2014).
[Crossref] [PubMed]

Neurosurgery (1)

H. A. Zaidi, A. A. Abla, P. Nakaji, S. A. Chowdhry, F. C. Albuquerque, and R. F. Spetzler, “Indocyanine green angiography in the surgical management of cerebral arteriovenous malformations: lessons learned in 130 consecutive cases,” Neurosurgery 10Suppl 2, 246–251 (2014).
[Crossref] [PubMed]

Phys. Med. Biol. (1)

J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, “Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection,” Phys. Med. Biol. 58(12), 3965–3977 (2013).
[Crossref] [PubMed]

Proc. Natl. Acad. Sci. U.S.A. (1)

C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, “Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform,” Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011).
[Crossref] [PubMed]

Protein Pept. Lett. (1)

V. Agrawal, J. H. Woo, G. Borthakur, H. Kantarjian, and A. E. Frankel, “Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia,” Protein Pept. Lett. 20(4), 392–402 (2013).
[PubMed]

Radiology (1)

E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, and M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study,” Radiology 246(3), 734–741 (2008).
[Crossref] [PubMed]

Sci. Rep. (1)

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Sci. Rep. 3, 2180 (2013).
[Crossref] [PubMed]

Science (2)

P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, and D. E. Discher, “Minimal “Self” Peptides That Inhibit Phagocytic Clearance And Enhance Delivery Of Nanoparticles,” Science 339(6122), 971–975 (2013).
[Crossref] [PubMed]

P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, “Role of CD47 as a marker of self on red blood cells,” Science 288(5473), 2051–2054 (2000).
[Crossref] [PubMed]

Small (2)

P. Sharma, N. E. Bengtsson, G. A. Walter, H. B. Sohn, G. Zhou, N. Iwakuma, H. Zeng, S. R. Grobmyer, E. W. Scott, and B. M. Moudgil, “Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging,” Small 8(18), 2856–2868 (2012).
[Crossref] [PubMed]

L. Rao, L. L. Bu, J. H. Xu, B. Cai, G. T. Yu, X. Yu, Z. He, Q. Huang, A. Li, S. S. Guo, W. F. Zhang, W. Liu, Z. J. Sun, H. Wang, T. H. Wang, and X. Z. Zhao, “Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance,” Small 11(46), 6225–6236 (2015).
[Crossref] [PubMed]

Ther. Deliv. (1)

C. Gutiérrez Millán, C. I. Colino Gandarillas, M. L. Sayalero Marinero, and J. M. Lanao, “Cell-based drug-delivery platforms,” Ther. Deliv. 3(1), 25–41 (2012).
[Crossref] [PubMed]

Urology (1)

S. Jeschke, L. Lusuardi, A. Myatt, S. Hruby, C. Pirich, and G. Janetschek, “Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging,” Urology 80(5), 1080–1087 (2012).
[Crossref] [PubMed]

Other (1)

T. Tadros, “Steric Stabilization,” in Encyclopedia of Colloid and Interface Science, T. Tadros, ed. (Springer Berlin Heidelberg, Berlin, Heidelberg, 2013), pp. 1048–1049.

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (8)

Fig. 1
Fig. 1 Schematic of the methodology to fabricate NETs functionalized with antibodies. The various steps are defined as follows: (1) hemoglobin depletion; (2) lipid insertion of linker molecule DSPE-PEG-NH2; (3) sequential extrusion through 400 nm and 100 nm porous membranes, and ICG loading; (4a) antibody oxidation to activate the aldehyde groups; and (4b) antibody conjugation by reductive amination.
Fig. 2
Fig. 2 (a) Diameter distributions of non-functionalized, and anti-HER2 functionalized NETs as determined by dynamic light scattering. We present the mean of three measurements on each of the samples with error bars representing the standard deviations from the mean. We fitted Lorentzian functions to the measured diameter distributions (solid curves). (b) Illustrative SEM image of anti-HER2 functionalized NETs. Scale bar = 500 nm.
Fig. 3
Fig. 3 (a) Fluorescence emission spectra of non-functionalized NETs, and NETs functionalized with primary and FITC-labeled secondary antibodies. Photo-excitation wavelength was 488 nm, and fluorescence emissions > 508 nm were recorded. (b) Extinction spectra of non-functionalized, and anti-HER2 functionalized NETs. (c) Fluorescence emission spectra of non-functionalized and anti-HER2 functionalized NETs. Photo-excitation wavelength was 650 nm, and fluorescence emissions > 665 nm were recorded.
Fig. 4
Fig. 4 Hydrodynamic diameter distributions for (a) non-functionalized, and (b) anti-HER2 functionalized NETs incubated in 1x PBS, RPMI 1640 cell culture medium, and RPMI 1640 + 10% FBS. Each symbol on the plots represents the average diameter value of three populations of either non-functionalized or anti-HER2 functionalized NETs. Measurements were fitted by Lorentzian functions (solid traces).
Fig. 5
Fig. 5 Time-dependent absorption spectra of non-functionalized NETs post-fabrication.
Fig. 6
Fig. 6 Fluorescence emission spectra of micron-sized EGs (non-extruded) (positive control), nano-sized NETs (extruded) conjugated with FITC-labeled anti-CD47, and Texas Red-labeled liposomes (negative control). Emission spectra from EGs and NETs show FITC-associated spectral peaks at 520 nm (488 nm photo-excitation wavelength), indicating the presence of CD47. Liposomes exhibited an emission peak associated with Texas Red at 609 nm (488 nm photo-excitation wavelength).
Fig. 7
Fig. 7 Fluorescent images of (a) OVCAR3 cells (low HER2 expression), and (b) SKOV3 cells (high HER2 expression) following two hours of incubation at 37 °C with anti-HER2 functionalized NETs. Images are falsely colored. Blue channel: DAPI. Red channel: NIR emission due to ICG. (c) NIR fluorescence emission of images (a-b) integrated over the spectral band > 770 nm.
Fig. 8
Fig. 8 Fluorescent images of SKOV3 cells following two hours of incubation at 37 °C with (a) 1x PBS, (b) free ICG, (c) non-functionalized NETs, and (d) anti-HER2 functionalized NETs. Images are falsely colored. Blue channel: DAPI. Red channel: NIR emission due to ICG. (e) NIR fluorescence emission of images (a-d) integrated over the spectral band >770 nm.

Metrics